(Q44646831)

English

Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex

scientific article published on November 28, 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Protective effect of LY379268, a selective group II metabotropic glutamate receptor agonist, on dizocilpine-induced neuropathological changes in rat retrosplenial cortex (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kenji Hashimoto

2

object named as

Kenji Hashimoto

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14604779

29 March 2024

author name string

Naoe Okamura

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Eiji Shimizu

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Kaori Koike

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Shintaro Ohgake

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Hiroki Koizumi

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Chikara Kumakiri

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Naoya Komatsu

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Masaomi Iyo

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

0 references

publication date

1 November 2003

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

28 November 2003

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14604779

29 March 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0006899303036400?httpAccept=text/xml

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

https://api.elsevier.com/content/article/PII:S0006899303036400?httpAccept=text/plain

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

992

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

114-119

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Metabotropic glutamate receptor subtypes as targets for neuroprotective drugs

1

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Regulation of neurotransmitter release by metabotropic glutamate receptors

2

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Attenuation of specific PCP-evoked behaviors by the potent mGlu2/3 receptor agonist, LY379268 and comparison with the atypical antipsychotic, clozapine

3

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Acute increases in monoamine release in the rat prefrontal cortex by the mGlu2/3 agonist LY379268 are similar in profile to risperidone, not locally mediated, and can be elicited in the presence of uptake blockade

4

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Molecular determinants of metabotropic glutamate receptor signaling.

5

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity

6

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

7

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Effects of antipsychotic drugs on neurotoxicity, expression of fos-like protein and c-fos mRNA in the retrosplenial cortex after administration of dizocilpine

9

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Genetic animal models: focus on schizophrenia

10

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Induction of heat shock protein (HSP)-70 in posterior cingulate and retrosplenial cortex of rat brain by dizocilpine and phencyclidine: lack of protective effects of sigma receptor ligands

11

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Rolipram, a selective phosphodiesterase type-IV inhibitor, prevents induction of heat shock protein HSP-70 and hsp-70 mRNA in rat retrosplenial cortex by the NMDA receptor antagonist dizocilpine.

12

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Dizocilpine-induced neuropathological changes in rat retrosplenial cortex are reversed by subsequent clozapine treatment

13

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Recent advances in the phencyclidine model of schizophrenia

14

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and alpha2-adrenergic agonists

15

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

16

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Reversal of phencyclidine effects by a group II metabotropic glutamate receptor agonist in rats

17

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders?

18

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Protective effect of the antipsychotic drug zotepine on dizocilpine-induced neuropathological changes in rat retrosplenial cortex.

19

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Glutamate receptor dysfunction and schizophrenia

20

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

21

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex

23

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia?

24

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus

25

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

The group II metabotropic glutamate receptor agonist (-)-2-oxa-4-aminobicyclo[3.1.0.]hexane-4,6-dicarboxylate (LY379268) and clozapine reverse phencyclidine-induced behaviors in monoamine-depleted rats

26

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Schizophrenia and glutamatergic transmission

27

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex

28

1 reference

10.1016/J.BRAINRES.2003.08.045

https://api.crossref.org/works/10.1016/J.BRAINRES.2003.08.045

29 March 2024

Identifiers

10.1016/J.BRAINRES.2003.08.045

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44646831&oldid=2114038094"